Outcomes Associated with a Patient Blood Management Program in Major Obstetric Hemorrhage: A Retrospective Cohort Study
Authors' conclusion
In women with a major obstetric hemorrhage of 2000 mL or greater, the implementation of an obstetric PBM program was associated with reduced blood product utilization, reduced costs, reduced anemia, and increased hemoglobin rise postdischarge.
Study context
- Population
- Women with major obstetric hemorrhage of 2000 mL or greater admitted to The Corniche Hospital, 2018–2023
- Participants
- 353 women
- Exposure
- Baseline year vs final year of an obstetric patient blood management (PBM) program
- Outcome
- Units of red blood cell (RBC), fresh-frozen plasma (FFP) and platelets transfused
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
P for trend < 0.001
Observational data: associations, not effects.
Secondary outcomes
Hb rise 3 weeks postdischarge
| Outcome | P value |
|---|---|
| Anaemia predelivery · 2018 vs 2023 | P for trend = 0.015 |
| Pretransfusion Hb in nonactively bleeding patients · 2018 vs 2023 | P for trend < 0.001 |
Blood product-acquisition cost savings · 2018 vs 2023
- Blood acquisition savings
- US$ 175,705
Adjusted composite morbidity, hospital and high-dependency unit LOS
- No changes in adjusted composite morbidity, hospital or high-dependency unit LOS
Safety
Adjusted composite morbidity (transfusion reaction, acute lung injury, thrombosis, sepsis, postpartum hysterectomy)
- No changes in adjusted composite morbidity
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →